1. Wiman B. Human α2-antiplasmin. Methods Enzymol 1981; 80: 395–408.
2. Kluft C. α2-Antiplasmin activity. In: Jespersen J, Bertina RM, Haverkate F, eds. ECAT assay procedures: a manual of laboratory techniques. Dordrecht: Kluwer, 1992; 165–171.
3. Blombäck M, Abildgaard U, van den Besselaar AM, Clementson KJ, Dahlbäck B, Exner T, Francis CW, Gaffney P, Gralnick H, Hoyer LW et al. Nomenclature of quantities and units in thrombosis and haemostasis (recommendation 1993). A collaborative project of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (ISTH/SSC) and the Commission/Committee on Quantities and Units (in Clinical Chemistry) of the International Union of Pure and Applied Chemistry-International Federation of Clinical Chemistry (IUPAC-IFCC/CQU(CC). Thromb Haemostas 1994; 71: 375–394.
4. Collen D, Wiman B. Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasma. Blood 1979; 53: 313–324.
5. Knot EAR, Drijfhout HR, Ten Cate JW, De Jong E, Iburg AHC, Kahlé LH, Grijm R. α2-Plasmin inhibitor metabolism in patients with liver cirrhosis. J Lab Clin Med 1985; 105: 353–361.